However, future work should examine whether the level of sustained energy expenditure that we observe with combined Gαq and Gαs signalling is sufficient to improve systemic metabolic parameters in the context of obesity-accelerated glucose intolerance, insulin resistance and tissue inflammation and fibrosis. The gene discussed is GNAQ; the disease is Obesity.